LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lifeline for cancer patients: extended drug access trial
Disease control OngoingThis study provides continued access to the cancer drug ibrutinib for patients who benefited from it in previous clinical trials but cannot obtain it through regular commercial channels. It allows about 300 patients with various blood cancers or solid tumors to keep receiving the…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE4 • Sponsor: Pharmacyclics Switzerland GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists track patients for 15 years after revolutionary cancer treatment
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows people for up to 15 years after they received CAR T-cell gene therapy for blood cancers like lymphoma and leukemia. Researchers check in annually through clinic visits, phone calls, or emails to monitor for any long-term side effects or health issues. The study…
Matched conditions: LEUKEMIA, B-CELL
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC